aica ribonucleotide has been researched along with Astrocytoma, Grade IV in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cloughesy, TF; Czernin, J; Dang, J; Guo, D; Hildebrandt, IJ; Mazzotta, MM; Mischel, PS; Phelps, M; Prins, RM; Radu, CG; Shyy, JY; Soto, H; Watson, AD | 1 |
1 other study(ies) available for aica ribonucleotide and Astrocytoma, Grade IV
Article | Year |
---|---|
The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Glioblastoma; Humans; Lipogenesis; Mice; Protein Kinases; PTEN Phosphohydrolase; Ribonucleotides; Ribosomal Protein S6 Kinases; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2009 |